2016 Annual Meeting | Evaluation and Management of Autonomic Disorders II
| 03:30 PM - 04:20 PM |
Disorders of Thermoregulation
William P. Cheshire, Jr., MD, FAAN |
|
| 04:20 PM - 05:20 PM |
Autonomic Peripheral Neuropathies
Roy L. Freeman, MD |
|
| 05:20 PM - 05:30 PM |
Questions and Answers
|
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron. |
| Paola Sandroni, MD, PhD, FAAN | Dr. Sandroni has nothing to disclose. |
| William P. Cheshire, Jr., MD, FAAN | Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities. |